Item 7.01 Regulation FD Disclosure.On December 8, 2022, Immunovant, Inc., or the Company, will participate in a virtual fireside chat hosted by LifeSci Capital LLC. A copy of the presentation to be used during the call is attached hereto as Exhibit 99.1 and is incorporated herein by reference.The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or the Exchange Act, or subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, or the Securities Act. The information in this Item 7.01, including Exhibit 99.1, shall not be deemed incorporate(…)
The Latest Press Releases